Tapewire

NYSE · USD

CHPT

ChargePoint Holdings, Inc.

Export transactions ↓
Tapewire entity
6581
SEC CIK
0001777393
Parsed reports
520

Last 12 months

Inside the activity.

1 purchase rows · 17 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202504
Jan 202600
Feb 202600
Mar 202604
Apr 202610
May 202600
Jun 202605
Jul 202600
Aug 202600
Sep 202604
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 01, 2022 Filed Jun 3, 2022 20:17 UTC
JACKSON REX SChief Financial Officer
GrantCommon Stock 358,166 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-021110 · doc4.xml · nonDerivative · entry 2

JACKSON REX S · CIK 0001249803 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,135,057

F2 · shares: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

F2 · price: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:17 UTC
JACKSON REX SChief Financial Officer
GrantCommon Stock 331,272 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-021110 · doc4.xml · nonDerivative · entry 1

JACKSON REX S · CIK 0001249803 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 776,891

F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:16 UTC
Hughes Michael DSee Remarks
GrantCommon Stock 358,166 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-021108 · doc4.xml · nonDerivative · entry 2

Hughes Michael D · CIK 0001590392 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 972,855

F2 · shares: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

F2 · price: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

Read SEC document
June 01, 2022 Filed Jun 3, 2022 20:16 UTC
Hughes Michael DSee Remarks
GrantCommon Stock 331,272 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-021108 · doc4.xml · nonDerivative · entry 1

Hughes Michael D · CIK 0001590392 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 614,689

F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

Read SEC document
June 01, 2022 Filed Jun 4, 2022 00:21 UTC
Jansen ColleenChief Marketing Officer
GrantCommon Stock 119,388 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-021119 · doc4.xml · nonDerivative · entry 2

Jansen Colleen · CIK 0001837912 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 591,825

F2 · shares: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

F2 · price: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

Read SEC document
June 01, 2022 Filed Jun 4, 2022 00:21 UTC
Jansen ColleenChief Marketing Officer
GrantCommon Stock 110,424 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-021119 · doc4.xml · nonDerivative · entry 1

Jansen Colleen · CIK 0001837912 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 472,437

F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

Read SEC document
June 01, 2022 Filed Jun 4, 2022 00:20 UTC
Chavez RebeccaGeneral Counsel and Secretary
GrantCommon Stock 95,510 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-021117 · doc4.xml · nonDerivative · entry 2

Chavez Rebecca · CIK 0001847025 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,786

F2 · shares: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

F2 · price: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

Read SEC document
June 01, 2022 Filed Jun 4, 2022 00:20 UTC
Chavez RebeccaGeneral Counsel and Secretary
GrantCommon Stock 88,339 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-021117 · doc4.xml · nonDerivative · entry 1

Chavez Rebecca · CIK 0001847025 · General Counsel and Secretary

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 169,276

F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

Read SEC document
June 01, 2022 Filed Jun 4, 2022 00:19 UTC
Romano PasqualeDirector · President and CEO
GrantCommon Stock 716,332 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-021116 · doc4.xml · nonDerivative · entry 2

Romano Pasquale · CIK 0001838832 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,145,304

F2 · shares: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 3-year period commencing on June 20, 2024 with respect to 1/12th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

F2 · price: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 3-year period commencing on June 20, 2024 with respect to 1/12th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

Read SEC document
June 01, 2022 Filed Jun 4, 2022 00:19 UTC
Romano PasqualeDirector · President and CEO
GrantCommon Stock 662,544 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-021116 · doc4.xml · nonDerivative · entry 1

Romano Pasquale · CIK 0001838832 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,428,972

F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period after June 20, 2024 with respect to 1/12th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 3-year period after June 20, 2024 with respect to 1/12th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

Read SEC document
June 01, 2022 Filed Jun 4, 2022 00:19 UTC
Sidle EricChief Technology Officer
GrantCommon Stock 143,266 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-021115 · doc4.xml · nonDerivative · entry 2

Sidle Eric · CIK 0001837954 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 619,271

F2 · shares: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

F2 · price: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

Read SEC document
June 01, 2022 Filed Jun 4, 2022 00:19 UTC
Sidle EricChief Technology Officer
GrantCommon Stock 132,508 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-021115 · doc4.xml · nonDerivative · entry 1

Sidle Eric · CIK 0001837954 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 476,005

F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

Read SEC document
June 01, 2022 Filed Jun 4, 2022 00:18 UTC
Loewenthal William JChief Product Officer
GrantCommon Stock 119,388 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-021114 · doc4.xml · nonDerivative · entry 2

Loewenthal William J · CIK 0001837881 · Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 447,538

F2 · shares: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

F2 · price: The Reporting Person was granted performance restricted stock units ("PRSUs"), which represent a contingent right to receive one share of Common Stock for each PRSU. The actual PRSUs awarded shall be earned upon the Issuer's common stock achieving certain price per share targets, as determined upon certification of the Issuer's Compensation & Organizational Development Committee. If earned, the eligible PRSUs will vest over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

Read SEC document
June 01, 2022 Filed Jun 4, 2022 00:18 UTC
Loewenthal William JChief Product Officer
GrantCommon Stock 110,424 Not disclosed Not disclosed
Disclosure

SEC source: 0000899243-22-021114 · doc4.xml · nonDerivative · entry 1

Loewenthal William J · CIK 0001837881 · Chief Product Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 328,150

F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

F1 · price: The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Common Stock for each RSU. The RSUs are subject to a service-based vesting requirement, which shall be satisfied over a 5-year period commencing on June 20, 2022 with respect to 1/20th quarterly thereafter, provided that the Reporting Person remains in continuous service on each such vesting date. Quarterly vesting dates are September 20, December 20, March 20 and June 20.

Read SEC document
May 22, 2022 Filed May 16, 2022 21:00 UTC
Loewenthal William JSenior Vice President, Product
Exercise / conversionStock Option (right to buy) · Derivative 25,000 Not disclosed Strike: $0.56 Not disclosed
Disclosure

SEC source: 0000899243-22-018162 · doc4.xml · derivative · entry 2

Loewenthal William J · CIK 0001837881 · Senior Vice President, Product

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 72,934

Underlying: Common Stock · 25,000 shares

Expires 2028-08-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: The Stock Option was received in exchange for an option to purchase shares of common stock of ChargePoint, Inc. in connection with the merger pursuant to the terms of that certain Business Combination Agreement and Plan of Reorganization, dated as of September 23, 2020.

F1 · derivative.exercise_date: The Stock Option vests in 48 equal monthly installments from July 30, 2018, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
May 17, 2022 Filed May 19, 2022 17:00 UTC
JACKSON REX SChief Financial Officer
Exercise / conversionStock Option (right to buy) · Derivative 50,196 Not disclosed Strike: $0.56 Not disclosed
Disclosure

SEC source: 0000899243-22-018860 · doc4.xml · derivative · entry 3

JACKSON REX S · CIK 0001249803 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,476,060

Underlying: Common Stock · 50,196 shares

Expires 2028-07-05

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: The Stock Option was received in exchange for an option to purchase shares of common stock of ChargePoint, Inc. in connection with the merger pursuant to the terms of that certain Business Combination Agreement and Plan of Reorganization, dated as of September 23, 2020.

F2 · derivative.exercise_date: The Stock Option vests in 48 equal monthly installments from May 29, 2018, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
May 17, 2022 Filed May 19, 2022 17:00 UTC
JACKSON REX SChief Financial Officer
Exercise / conversionCommon Stock 50,196 $0.56 $28,109.76
Disclosure

SEC source: 0000899243-22-018860 · doc4.xml · nonDerivative · entry 1

JACKSON REX S · CIK 0001249803 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 445,619

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 12, 2022 Filed May 16, 2022 21:00 UTC
Loewenthal William JSenior Vice President, Product
Exercise / conversionCommon Stock 25,000 $0.56 $14,000.00
Disclosure

SEC source: 0000899243-22-018162 · doc4.xml · nonDerivative · entry 1

Loewenthal William J · CIK 0001837881 · Senior Vice President, Product

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 217,726

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 22, 2022 Filed Apr 26, 2022 21:00 UTC
Romano PasqualeDirector · President and CEO
Exercise / conversionStock Option (right to buy) · Derivative 250,000 Not disclosed Strike: $0.27 Not disclosed
Disclosure

SEC source: 0000899243-22-015660 · doc4.xml · derivative · entry 3

Romano Pasquale · CIK 0001838832 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 250,802

Underlying: Common Stock · 250,000 shares

Expires 2022-06-10

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · price: The Stock Option was received in exchange for an option to purchase shares of common stock of ChargePoint, Inc. in connection with the merger pursuant to the terms of that certain Business Combination Agreement and Plan of Reorganization, dated as of September 23, 2020.

Read SEC document
April 22, 2022 Filed Apr 26, 2022 21:00 UTC
Romano PasqualeDirector · President and CEO
SaleCommon Stock 250,000 $14.62 $3,655,125.00
Disclosure

SEC source: 0000899243-22-015660 · doc4.xml · nonDerivative · entry 2

Romano Pasquale · CIK 0001838832 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,766,428

F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F3 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $14.32 to $15.15. The Reporting Person has provided to the issuer and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 22, 2022 Filed Apr 26, 2022 21:00 UTC
Romano PasqualeDirector · President and CEO
Exercise / conversionCommon Stock 250,000 $0.27 $67,500.00
Disclosure

SEC source: 0000899243-22-015660 · doc4.xml · nonDerivative · entry 1

Romano Pasquale · CIK 0001838832 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,016,428

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The Reporting Person exercised these options, which otherwise will expire on June 10, 2022, for shares of common stock to be sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
April 14, 2022 Filed Apr 15, 2022 21:05 UTC
Linse MichaelDirector · 10% owner
SaleCommon Stock 9,841 $16.14 $158,833.74
Disclosure

SEC source: 0000899243-22-014901 · doc4.xml · nonDerivative · entry 6

Linse Michael · CIK 0001838841 · Director · 10% owner

Linse Capital CP, LLC · CIK 0001672172 · 10% owner

Linse Capital CP II LLC · CIK 0001687199 · 10% owner

Linse Capital CP III, LLC · CIK 0001698115 · 10% owner

Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner

Linse Capital CP V, LLC · CIK 0001758721 · 10% owner

Linse Capital LLC · CIK 0001849040 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 0

F6 · ownership.nature: Consists of securities held directly by Levitate Capital GP LP ("Levitate GP"). Linse Capital Management PR LLC ("LCMPR") is the general partner of Levitate GP. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of LCMPR. Mr. Linse has sole voting and investment power over the shares held by Levitate GP.

F9 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held an aggregate of 0 shares of Common Stock.

Read SEC document
April 14, 2022 Filed Apr 15, 2022 21:05 UTC
Linse MichaelDirector · 10% owner
SaleCommon Stock 29,333 $16.17 $474,314.61
Disclosure

SEC source: 0000899243-22-014901 · doc4.xml · nonDerivative · entry 5

Linse Michael · CIK 0001838841 · Director · 10% owner

Linse Capital CP, LLC · CIK 0001672172 · 10% owner

Linse Capital CP II LLC · CIK 0001687199 · 10% owner

Linse Capital CP III, LLC · CIK 0001698115 · 10% owner

Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner

Linse Capital CP V, LLC · CIK 0001758721 · 10% owner

Linse Capital LLC · CIK 0001849040 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 4,794,993

F5 · ownership.nature: Consists of securities held directly by Linse Capital CP V, LLC ("Linse V"). Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse V. Mr. Linse has sole voting and investment power over the shares held by Linse V.

F9 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held an aggregate of 0 shares of Common Stock.

Read SEC document
April 14, 2022 Filed Apr 15, 2022 21:05 UTC
Linse MichaelDirector · 10% owner
SaleCommon Stock 25,000 $16.22 $405,500.00
Disclosure

SEC source: 0000899243-22-014901 · doc4.xml · nonDerivative · entry 4

Linse Michael · CIK 0001838841 · Director · 10% owner

Linse Capital CP, LLC · CIK 0001672172 · 10% owner

Linse Capital CP II LLC · CIK 0001687199 · 10% owner

Linse Capital CP III, LLC · CIK 0001698115 · 10% owner

Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner

Linse Capital CP V, LLC · CIK 0001758721 · 10% owner

Linse Capital LLC · CIK 0001849040 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 4,526,626

F4 · ownership.nature: Consists of securities held directly by Linse Capital CP IV, LLC ("Linse IV"). Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse IV. Mr. Linse has sole voting and investment power over the shares held by Linse IV.

F9 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held an aggregate of 0 shares of Common Stock.

Read SEC document
April 14, 2022 Filed Apr 15, 2022 21:05 UTC
Linse MichaelDirector · 10% owner
SaleCommon Stock 1,333 $16.15 $21,527.95
Disclosure

SEC source: 0000899243-22-014901 · doc4.xml · nonDerivative · entry 3

Linse Michael · CIK 0001838841 · Director · 10% owner

Linse Capital CP, LLC · CIK 0001672172 · 10% owner

Linse Capital CP II LLC · CIK 0001687199 · 10% owner

Linse Capital CP III, LLC · CIK 0001698115 · 10% owner

Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner

Linse Capital CP V, LLC · CIK 0001758721 · 10% owner

Linse Capital LLC · CIK 0001849040 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 6,540,386

F3 · ownership.nature: Consists of securities held directly by Linse Capital CP III, LLC ("Linse III"). Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse III. Mr. Linse has the sole voting and investment power over the shares held by Linse III.

F9 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held an aggregate of 0 shares of Common Stock.

Read SEC document
April 14, 2022 Filed Apr 15, 2022 21:05 UTC
Linse MichaelDirector · 10% owner
SaleCommon Stock 14,333 $16.15 $231,477.95
Disclosure

SEC source: 0000899243-22-014901 · doc4.xml · nonDerivative · entry 2

Linse Michael · CIK 0001838841 · Director · 10% owner

Linse Capital CP, LLC · CIK 0001672172 · 10% owner

Linse Capital CP II LLC · CIK 0001687199 · 10% owner

Linse Capital CP III, LLC · CIK 0001698115 · 10% owner

Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner

Linse Capital CP V, LLC · CIK 0001758721 · 10% owner

Linse Capital LLC · CIK 0001849040 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 5,812,908

F2 · ownership.nature: Consists of securities held directly by Linse Capital CP II, LLC ("Linse II"). Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse II. Mr. Linse has sole voting and investment power over the shares held by Linse II.

F9 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held an aggregate of 0 shares of Common Stock.

Read SEC document
April 14, 2022 Filed Apr 15, 2022 21:05 UTC
Linse MichaelDirector · 10% owner
SaleCommon Stock 1,333 $16.14 $21,514.62
Disclosure

SEC source: 0000899243-22-014901 · doc4.xml · nonDerivative · entry 1

Linse Michael · CIK 0001838841 · Director · 10% owner

Linse Capital CP, LLC · CIK 0001672172 · 10% owner

Linse Capital CP II LLC · CIK 0001687199 · 10% owner

Linse Capital CP III, LLC · CIK 0001698115 · 10% owner

Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner

Linse Capital CP V, LLC · CIK 0001758721 · 10% owner

Linse Capital LLC · CIK 0001849040 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 20,075,404

F1 · ownership.nature: Consists of securities held directly by Linse Capital CP, LLC ("Linse I"). Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse I. Mr. Linse has sole voting and investment power over the shares held by Linse I.

F9 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held an aggregate of 0 shares of Common Stock.

Read SEC document
April 12, 2022 Filed Apr 13, 2022 20:57 UTC
Linse MichaelDirector · 10% owner
OtherCommon Stock 226,068 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-014754 · doc4.xml · nonDerivative · entry 7

Linse Michael · CIK 0001838841 · Director · 10% owner

Linse Capital CP VI LLC · CIK 0001821364 · 10% owner

Linse Capital CP, LLC · CIK 0001672172 · 10% owner

Linse Capital CP II LLC · CIK 0001687199 · 10% owner

Linse Capital CP III, LLC · CIK 0001698115 · 10% owner

Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner

Linse Capital CP V, LLC · CIK 0001758721 · 10% owner

Linse Capital LLC · CIK 0001849040 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 20,532

F13 · kind: On April 11, 2022, 226,068 shares of Common Stock held by Linse GP VI were distributed to the limited partners and general partners of Linse GP VI.

F14 · ownership.nature: Consists of securities held by Linse GP VI. LCMPR is the general partner of Linse GP VI. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of LCMPR. Mr. Linse has sole voting and investment power over the shares held by Linse GP VI.

F15 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held [0] shares of Common Stock.

Read SEC document
April 12, 2022 Filed Apr 15, 2022 21:05 UTC
Linse MichaelDirector · 10% owner
SaleCommon Stock 1,576,794 $15.46 $24,377,235.24
Disclosure

SEC source: 0000899243-22-014901 · doc4.xml · nonDerivative · entry 7

Linse Michael · CIK 0001838841 · Director · 10% owner

Linse Capital CP, LLC · CIK 0001672172 · 10% owner

Linse Capital CP II LLC · CIK 0001687199 · 10% owner

Linse Capital CP III, LLC · CIK 0001698115 · 10% owner

Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner

Linse Capital CP V, LLC · CIK 0001758721 · 10% owner

Linse Capital LLC · CIK 0001849040 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 0

F7 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.20 to $16.09, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.

F8 · ownership.nature: Consists of securities held directly by Linse Capital LLC. Mr. Linse is the managing director of Linse Capital LLC. Mr. Linse has sole voting and investment power over the shares held by Linse Capital LLC.

F9 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held an aggregate of 0 shares of Common Stock.

Read SEC document
April 11, 2022 Filed Apr 13, 2022 20:57 UTC
Linse MichaelDirector · 10% owner
OtherCommon Stock 1,314,768 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-014754 · doc4.xml · nonDerivative · entry 6

Linse Michael · CIK 0001838841 · Director · 10% owner

Linse Capital CP VI LLC · CIK 0001821364 · 10% owner

Linse Capital CP, LLC · CIK 0001672172 · 10% owner

Linse Capital CP II LLC · CIK 0001687199 · 10% owner

Linse Capital CP III, LLC · CIK 0001698115 · 10% owner

Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner

Linse Capital CP V, LLC · CIK 0001758721 · 10% owner

Linse Capital LLC · CIK 0001849040 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 7,639,558

F11 · kind: On April 11, 2022, 1,314,768 shares of Common Stock held by Linse Capital CP VI, LLC ("Linse VI") were distributed to the limited partners and general partners of Linse VI.

F12 · ownership.nature: Consists of securities held directly by Linse VI. Linse Capital CP VI GP LP ("Linse GP VI") is the manager of Linse VI, and Linse Capital Management PR LLC ("LCMPR") is the general partner of Linse GP VI. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of LCMPR. Mr. Linse has sole voting and investment power over the shares held by Linse VI.

F15 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held [0] shares of Common Stock.

Read SEC document
April 11, 2022 Filed Apr 13, 2022 20:57 UTC
Linse MichaelDirector · 10% owner
OtherCommon Stock 795,885 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-014754 · doc4.xml · nonDerivative · entry 5

Linse Michael · CIK 0001838841 · Director · 10% owner

Linse Capital CP VI LLC · CIK 0001821364 · 10% owner

Linse Capital CP, LLC · CIK 0001672172 · 10% owner

Linse Capital CP II LLC · CIK 0001687199 · 10% owner

Linse Capital CP III, LLC · CIK 0001698115 · 10% owner

Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner

Linse Capital CP V, LLC · CIK 0001758721 · 10% owner

Linse Capital LLC · CIK 0001849040 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 4,824,326

F9 · kind: On April 11, 2022, 795,885 shares of Common Stock held by Linse Capital CP V, LLC ("Linse V") were distributed to the limited partners and general partners of Linse V.

F10 · ownership.nature: Consists of securities held directly by Linse V. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse V. Mr. Linse has sole voting and investment power over the shares held by Linse V.

F15 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held [0] shares of Common Stock.

Read SEC document
April 11, 2022 Filed Apr 13, 2022 20:57 UTC
Linse MichaelDirector · 10% owner
OtherCommon Stock 754,032 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-014754 · doc4.xml · nonDerivative · entry 4

Linse Michael · CIK 0001838841 · Director · 10% owner

Linse Capital CP VI LLC · CIK 0001821364 · 10% owner

Linse Capital CP, LLC · CIK 0001672172 · 10% owner

Linse Capital CP II LLC · CIK 0001687199 · 10% owner

Linse Capital CP III, LLC · CIK 0001698115 · 10% owner

Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner

Linse Capital CP V, LLC · CIK 0001758721 · 10% owner

Linse Capital LLC · CIK 0001849040 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 4,551,626

F7 · kind: On April 11, 2022, 754,032 shares of Common Stock held by Linse Capital CP IV, LLC ("Linse IV") were distributed to the limited partners and general partners of Linse IV.

F8 · ownership.nature: Consists of securities held directly by Linse IV. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse IV. Mr. Linse has sole voting and investment power over the shares held by Linse IV.

F15 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held [0] shares of Common Stock.

Read SEC document
April 11, 2022 Filed Apr 13, 2022 20:57 UTC
Linse MichaelDirector · 10% owner
OtherCommon Stock 1,124,268 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-014754 · doc4.xml · nonDerivative · entry 3

Linse Michael · CIK 0001838841 · Director · 10% owner

Linse Capital CP VI LLC · CIK 0001821364 · 10% owner

Linse Capital CP, LLC · CIK 0001672172 · 10% owner

Linse Capital CP II LLC · CIK 0001687199 · 10% owner

Linse Capital CP III, LLC · CIK 0001698115 · 10% owner

Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner

Linse Capital CP V, LLC · CIK 0001758721 · 10% owner

Linse Capital LLC · CIK 0001849040 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 6,541,719

F5 · kind: On April 11, 2022, 1,124,268 shares of Common Stock of Linse Capital CP III, LLC ("Linse III") were distributed to the limited partners and general partners of Linse III.

F6 · ownership.nature: Consists of securities held directly by Linse III. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse III. Mr. Linse has the sole voting and investment power over the shares held by Linse III.

F15 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held [0] shares of Common Stock.

Read SEC document
April 11, 2022 Filed Apr 13, 2022 20:57 UTC
Linse MichaelDirector · 10% owner
OtherCommon Stock 986,069 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-014754 · doc4.xml · nonDerivative · entry 2

Linse Michael · CIK 0001838841 · Director · 10% owner

Linse Capital CP VI LLC · CIK 0001821364 · 10% owner

Linse Capital CP, LLC · CIK 0001672172 · 10% owner

Linse Capital CP II LLC · CIK 0001687199 · 10% owner

Linse Capital CP III, LLC · CIK 0001698115 · 10% owner

Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner

Linse Capital CP V, LLC · CIK 0001758721 · 10% owner

Linse Capital LLC · CIK 0001849040 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 5,827,241

F3 · kind: On April 11, 2022, 986,069 shares of Common Stock held by Linse Capital CP II, LLC ("Linse II") were distributed to the limited partners and general partners of Linse II.

F4 · ownership.nature: Consists of securities held directly by Linse II. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse II. Mr. Linse has sole voting and investment power over the shares held by Linse II.

F15 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held [0] shares of Common Stock.

Read SEC document
April 11, 2022 Filed Apr 13, 2022 20:57 UTC
Linse MichaelDirector · 10% owner
OtherCommon Stock 3,453,646 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-014754 · doc4.xml · nonDerivative · entry 1

Linse Michael · CIK 0001838841 · Director · 10% owner

Linse Capital CP VI LLC · CIK 0001821364 · 10% owner

Linse Capital CP, LLC · CIK 0001672172 · 10% owner

Linse Capital CP II LLC · CIK 0001687199 · 10% owner

Linse Capital CP III, LLC · CIK 0001698115 · 10% owner

Linse Capital CP IV, LLC · CIK 0001725674 · 10% owner

Linse Capital CP V, LLC · CIK 0001758721 · 10% owner

Linse Capital LLC · CIK 0001849040 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: Not disclosed

Ownership: Indirect · See footnotes

Disclosed balance after: 20,076,737

F1 · kind: On April 11, 2022, 3,453,646 shares of Common Stock held by Linse Capital CP, LLC ("Linse I") were distributed to the limited partners and general partners of Linse I.

F2 · ownership.nature: Consists of securities held directly by Linse I. Mr. Linse is the managing director of Linse Capital LLC, which is the manager of Linse I. Mr. Linse has sole voting and investment power over the shares held by Linse I.

F15 · ownership.nature: Each of the Reporting Persons disclaims beneficial ownership of the securities in this report except to the extent of any pecuniary interest therein, and the filing of this report or the inclusion of the securities in this report shall not be deemed an admission that any of the Reporting Persons is the beneficial owner of the reported securities for purposes of Section 16 or for any other purpose. Following the transactions reported herein, Linse Capital LLC held [0] shares of Common Stock.

Read SEC document
April 11, 2022 Filed Apr 13, 2022 22:30 UTC OtherCommon Stock 3,895 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-014731 · doc4.xml · nonDerivative · entry 1

WAGONER G RICHARD JR · CIK 0001181664 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By trust

Disclosed balance after: 52,378

F1 · kind: Represents an acquisition of securities from an in-kind distribution, and not a purchase or sale, without additional consideration paid, and is therefore an exempt, non-matchable acquisition pursuant to Section 16(b).

F2 · ownership.nature: The shares are held by the G. Richard Wagoner, Jr. Trust dated 7/13/1989, as amended and restated 10/19/2018 of which the Reporting Person is trustee.

Read SEC document
April 05, 2022 Filed Apr 7, 2022 20:58 UTC GrantCommon Stock 17,131 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-014284 · doc4.xml · nonDerivative · entry 1

Singh-Bushell Ekta · CIK 0001707731 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,131

F1 · shares: The Reporting Person was granted restricted stock units ("RSUs"), each representing the right to receive one share of the issuer's common stock. The RSUs are subject to a service-based vesting requirement, which shall be satisfied in three annual installments on each anniversary of April 5, 2022, subject to the Reporting Person's continuous service with the issuer through each such anniversary.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 17:00 UTC
Hughes Michael DSee Remarks
Exercise / conversionStock Option (right to buy) · Derivative 25,000 Not disclosed Strike: $0.56 Not disclosed
Disclosure

SEC source: 0000899243-22-013804 · doc4.xml · derivative · entry 3

Hughes Michael D · CIK 0001590392 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,341,174

Underlying: Common Stock · 25,000 shares

Expires 2028-08-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: The Stock Option was received in exchange for an option to purchase shares of common stock of ChargePoint, Inc. in connection with the merger pursuant to the terms of that certain Business Combination Agreement and Plan of Reorganization, dated as of September 23, 2020. The Stock Option vests in 48 equal monthly installments from August 16, 2018, subject to the Reporting Person's continuous service through each vesting date.

F3 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase shares of common stock of ChargePoint, Inc. in connection with the merger pursuant to the terms of that certain Business Combination Agreement and Plan of Reorganization, dated as of September 23, 2020. The Stock Option vests in 48 equal monthly installments from August 16, 2018, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 17:00 UTC
Hughes Michael DSee Remarks
SaleCommon Stock 25,000 $19.73 $493,180.00
Disclosure

SEC source: 0000899243-22-013804 · doc4.xml · nonDerivative · entry 2

Hughes Michael D · CIK 0001590392 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 283,417

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $19.375 to $20.075. The Reporting Person has provided to the issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 17:00 UTC
Hughes Michael DSee Remarks
Exercise / conversionCommon Stock 25,000 $0.56 $14,000.00
Disclosure

SEC source: 0000899243-22-013804 · doc4.xml · nonDerivative · entry 1

Hughes Michael D · CIK 0001590392 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 308,417

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 21:00 UTC
Jansen ColleenChief Marketing Officer
Exercise / conversionStock Option (right to buy) · Derivative 3,500 Not disclosed Strike: $0.44 Not disclosed
Disclosure

SEC source: 0000899243-22-013805 · doc4.xml · derivative · entry 3

Jansen Colleen · CIK 0001837912 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 359,192

Underlying: Common Stock · 3,500 shares

Expires 2026-07-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · price: The Stock Option was received in exchange for an option to purchase shares of common stock of ChargePoint, Inc. in connection with the merger pursuant to the terms of that certain Business Combination Agreement and Plan of Reorganization, dated as of September 23, 2020.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 21:00 UTC
Jansen ColleenChief Marketing Officer
SaleCommon Stock 3,500 $19.88 $69,580.00
Disclosure

SEC source: 0000899243-22-013805 · doc4.xml · nonDerivative · entry 2

Jansen Colleen · CIK 0001837912 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 362,013

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 21:00 UTC
Jansen ColleenChief Marketing Officer
Exercise / conversionCommon Stock 3,500 $0.44 $1,540.00
Disclosure

SEC source: 0000899243-22-013805 · doc4.xml · nonDerivative · entry 1

Jansen Colleen · CIK 0001837912 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 365,513

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 21:00 UTC
Sidle EricSee Remarks
Exercise / conversionStock Option (right to buy) · Derivative 30,000 Not disclosed Strike: $0.76 Not disclosed
Disclosure

SEC source: 0000899243-22-013802 · doc4.xml · derivative · entry 3

Sidle Eric · CIK 0001837954 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 238,979

Underlying: Common Stock · 30,000 shares

Expires 2029-05-28

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · price: The Stock Option was received in exchange for an option to purchase shares of common stock of ChargePoint, Inc. in connection with the merger pursuant to the terms of that certain Business Combination Agreement and Plan of Reorganization, dated as of September 23, 2020. The Stock Option vests in 48 equal monthly installments from May 29, 2019, subject to the Reporting Person's continuous service through each vesting date.

F3 · derivative.exercise_date: The Stock Option was received in exchange for an option to purchase shares of common stock of ChargePoint, Inc. in connection with the merger pursuant to the terms of that certain Business Combination Agreement and Plan of Reorganization, dated as of September 23, 2020. The Stock Option vests in 48 equal monthly installments from May 29, 2019, subject to the Reporting Person's continuous service through each vesting date.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 21:00 UTC
Sidle EricSee Remarks
SaleCommon Stock 30,000 $20.01 $600,360.00
Disclosure

SEC source: 0000899243-22-013802 · doc4.xml · nonDerivative · entry 2

Sidle Eric · CIK 0001837954 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 343,497

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.09. The Reporting Person has provided to the issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document
April 01, 2022 Filed Apr 5, 2022 21:00 UTC
Sidle EricSee Remarks
Exercise / conversionCommon Stock 30,000 $0.76 $22,800.00
Disclosure

SEC source: 0000899243-22-013802 · doc4.xml · nonDerivative · entry 1

Sidle Eric · CIK 0001837954 · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 373,497

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 25, 2022 Filed Mar 30, 2022 01:45 UTC
Jansen ColleenChief Marketing Officer
Exercise / conversionStock Option (right to buy) · Derivative 3,500 $0.00 Strike: $0.44 $0.00
Disclosure

SEC source: 0000899243-22-012735 · doc4.xml · derivative · entry 3

Jansen Colleen · CIK 0001837912 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 362,692

Underlying: Common Stock · 3,500 shares

Expires 2026-07-31

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 25, 2022 Filed Mar 30, 2022 01:45 UTC
Jansen ColleenChief Marketing Officer
SaleCommon Stock 3,500 $19.00 $66,500.00
Disclosure

SEC source: 0000899243-22-012735 · doc4.xml · nonDerivative · entry 2

Jansen Colleen · CIK 0001837912 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 362,013

F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.

Read SEC document
March 25, 2022 Filed Mar 30, 2022 01:45 UTC
Jansen ColleenChief Marketing Officer
Exercise / conversionCommon Stock 3,500 $0.44 $1,540.00
Disclosure

SEC source: 0000899243-22-012735 · doc4.xml · nonDerivative · entry 1

Jansen Colleen · CIK 0001837912 · Chief Marketing Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 365,513

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
March 22, 2022 Filed Mar 24, 2022 17:01 UTC
Gerdes HenrikChief Accounting Officer
SaleCommon Stock 552 $17.92 $9,891.23
Disclosure

SEC source: 0000899243-22-012106 · doc4.xml · nonDerivative · entry 1

Gerdes Henrik · CIK 0001688266 · Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,159

F1 · kind: The sale reported on this Form 4 represent shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

F2 · price: Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $17.77 to $17.92. The Reporting Person has provided to the issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.